Abstract
Background Little is known about prescription patterns of expensive non-recommended newer long-acting insulins (glargine 300 U/mL and degludec) for patients with type 2 diabetes mellitus (T2DM). Aim To identify practice variation in, and practice and patient-related characteristics associated with, the prescription of newer long-acting insulins to patients with T2DM in
... read more